Literature DB >> 18167340

Systemic spread is an early step in breast cancer.

Yves Hüsemann1, Jochen B Geigl, Falk Schubert, Piero Musiani, Manfred Meyer, Elke Burghart, Guido Forni, Roland Eils, Tanja Fehm, Gert Riethmüller, Christoph A Klein.   

Abstract

It is widely accepted that metastasis is a late event in cancer progression. Here, however, we show that tumor cells can disseminate systemically from earliest epithelial alterations in HER-2 and PyMT transgenic mice and from ductal carcinoma in situ in women. Wild-type mice transplanted with single premalignant HER-2 transgenic glands displayed disseminated tumor cells and micrometastasis in bone marrow and lungs. The number of disseminated cancer cells and their karyotypic abnormalities were similar for small and large tumors in patients and mouse models. When activated by bone marrow transplantation into wild-type recipients, 80 early-disseminated cancer cells sufficed to induce lethal carcinosis. Therefore, release from dormancy of early-disseminated cancer cells may frequently account for metachronous metastasis.

Entities:  

Mesh:

Year:  2008        PMID: 18167340     DOI: 10.1016/j.ccr.2007.12.003

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  477 in total

1.  Metastasis as a therapeutic target in prostate cancer: a conceptual framework.

Authors:  Konstantin Stoletov; David Bond; Katie Hebron; Srijan Raha; Andries Zijlstra; John D Lewis
Journal:  Am J Clin Exp Urol       Date:  2014-04

2.  Concurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis.

Authors:  Scott Valastyan; Amelia Chang; Nathan Benaich; Ferenc Reinhardt; Robert A Weinberg
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

3.  Muscarinic receptor agonists stimulate human colon cancer cell migration and invasion.

Authors:  Angelica Belo; Kunrong Cheng; Ahmed Chahdi; Jasleen Shant; Guofeng Xie; Sandeep Khurana; Jean-Pierre Raufman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-01-27       Impact factor: 4.052

Review 4.  Staying alive: metabolic adaptations to quiescence.

Authors:  James R Valcourt; Johanna M S Lemons; Erin M Haley; Mina Kojima; Olukunle O Demuren; Hilary A Coller
Journal:  Cell Cycle       Date:  2012-05-01       Impact factor: 4.534

5.  Metastasis: The rude awakening.

Authors:  Jocelyn Rice
Journal:  Nature       Date:  2012-05-30       Impact factor: 49.962

Review 6.  Circulating tumor cells in the diagnosis and management of pancreatic cancer.

Authors:  Putao Cen; Xiaoling Ni; Jingxuan Yang; David Y Graham; Min Li
Journal:  Biochim Biophys Acta       Date:  2012-06-07

7.  Antagonizing metastasis.

Authors:  Michele De Palma; Luigi Naldini
Journal:  Nat Biotechnol       Date:  2010-04       Impact factor: 54.908

8.  Early tumor dissemination, but late metastasis: insights into tumor dormancy.

Authors:  Martin Röcken
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

9.  An automated high-throughput counting method for screening circulating tumor cells in peripheral blood.

Authors:  Mengxia Zhao; Perry G Schiro; Jason S Kuo; Karen M Koehler; Daniel E Sabath; Viorica Popov; Qinghua Feng; Daniel T Chiu
Journal:  Anal Chem       Date:  2013-02-06       Impact factor: 6.986

10.  GRK3 is essential for metastatic cells and promotes prostate tumor progression.

Authors:  Wenliang Li; Nanping Ai; Suming Wang; Nandita Bhattacharya; Vladimir Vrbanac; Michael Collins; Sabina Signoretti; Yanhui Hu; Frederick M Boyce; Karsten Gravdal; Ole J Halvorsen; Hawa Nalwoga; Lars A Akslen; Ed Harlow; Randolph S Watnick
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.